See All News - tctmd.com

News

News Conference News ACC 2013

MASS COMM: On-site Surgical Back-up Not Necessary for Elective PCI

Jason Kahn

March 11, 2013

News Industry News

Cardiovascular Systems Presents Results from Pivotal Coronary Trial at ACC

March 11, 2013

News Conference News ACC 2013

Studies Fail to Tame Controversy Over Off- vs. On-Pump CABG

March 11, 2013

News Conference News ACC 2013

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

L.A. McKeown

March 11, 2013

News Conference News ACC 2013

Coronary CTA Predictive, Resource-Saving When Used in Emergency Department

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

Jason Kahn

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Industry News

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 11, 2013

News Industry News

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

March 09, 2013

Advertisement

News

MASS COMM: On-site Surgical Back-up Not Necessary for Elective PCI

Cardiovascular Systems Presents Results from Pivotal Coronary Trial at ACC

Studies Fail to Tame Controversy Over Off- vs. On-Pump CABG

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

Coronary CTA Predictive, Resource-Saving When Used in Emergency Department

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content